Yoo; Moo Hi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoo; Moo Hi.The latest application filed is for "acid addition salt of udenafil, preparation method thereof and pharmaceutical composition comprising the same".

Company Profile

0.7.13

Yoo; Moo Hi - Seoul N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Extract of herbal and composition containing the same Grant 8,765,197 - Son , et al. July 1, 2	2014-07-01
Three-branched polyethylene glycol-G-CSF conjugate Grant 8,329,191 - Jo , et al. December 11, 2	2012-12-11
1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation Grant 8,242,159 - Lee , et al. August 14, 2	2012-08-14
3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same Grant 8,203,011 - Choi , et al. June 19, 2	2012-06-19
Acid Addition Salt Of Udenafil, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same App 20110306762 - Lee; Chan-Ho ; et al.	2011-12-15
Controlled-release Composition For Producing Sustained-release Preparation Containing Udenafil App 20110250279 - Yoo; Moo-Hi ; et al.	2011-10-13
Crystal forms of pyrrolylheptanoic acid derivatives Grant 7,915,302 - Kim , et al. March 29, 2	2011-03-29
Stabilized Single-liquid Pharmaceutical Composition Containing Docetaxel App 20100267818 - Yoo; Moo-Hi ; et al.	2010-10-21
Novel 1,3-dihydro-5-isobenzofurancarbonitrile Derivatives And Pharmaceutical Composition Thereof For The Treatment Of Premature Ejaculation App 20100240725 - Lee; Yeong Geon ; et al.	2010-09-23
Composition And Method For Treatment Or Prevention Of Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms App 20100210668 - Choi; Seul-Min ; et al.	2010-08-19
Pharmaceutical Compositions For The Treatment Of Chronic Heart Failure Comprising Pyrazolopyrimidinone Derivative Compound App 20100173915 - Shin; Jee-Hyun ; et al.	2010-07-08
3',4',5-trimethoxy Flavone Derivatives As Stimulatn Of Mucus Secretion, Method For The Same, And Pharmaceutical Composition Comprising The Same App 20100130448 - Choi; Seul-Min ; et al.	2010-05-27
Novel Crystal Forms Of Pyrrolylheptanoic Acid Derivatives App 20100113556 - Kim; Moon Sung ; et al.	2010-05-06
Novel Benzamide Derivatives And Process For The Prepartion Thereof App 20100105727 - Yoo; Moo-Hi ; et al.	2010-04-29
Polyethylene Glycol-g-csf Conjugate App 20100105616 - Jo; Yeong-Woo ; et al.	2010-04-29
Novel Phenylpropionic Acid Derivatives As Peroxisome Proliferator-activated Gamma Receptor Modulators, Method Of The Same, And Pharmaceutical Composition Comprising The Same App 20100063041 - Moon; Ho-Sang ; et al.	2010-03-11
Extract Of Herbal And Composition Containing The Same App 20090186108 - Son; Mi Won ; et al.	2009-07-23
Preparing pyrazolopyrimidinone derivatives for the treatment of impotence Grant 6,844,436 - Yoo , et al. January 18, 2	2005-01-18
Preparing pyrazolopyrimidinone derivatives for the treatment of impotence App 20030176696 - Yoo, Moo-Hi ; et al.	2003-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.